Melphalan vs polymelphalanum in ovarian cancer patients resistant to cyclophosphamide: a tentative statistical approach to balance risks and benefits.
D003520:Cyclophosphamide / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008558:Melphalan / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012306:Risk; D013921:Thrombocytopenia / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced
D003520:Cyclophosphamide; D008558:Melphalan